VectorBuilder Redefines Plasmid Standards with miniVec
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
Marks first international filing for Evofem’s single-dose oral treatment
Investment to expand manufacturing and global medicine supply capacity
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Takeda will seek an external partner to leverage its cell therapy platform technologies
Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder for concentrate for solution for infusion is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC3+) solid tumors
Hyperion results presented at ERS 2025 and simultaneously published in the New England Journal of Medicine
India currently hosts more than 10,075 biotech startups
Subscribe To Our Newsletter & Stay Updated